TABLE OF CONTENTS

Figure S1
Global assessment of data distribution.
Figure S2
Principal Component Analysis (PCA) and hierarchical clustering analysis prior to accounting for batch effects.
Figure S3
Global changes in murine macrophage gene expression upon infection by L. major.
Figure S4
Expression patterns for the top 20 up-and down-regulated genes in L. majorinfected murine macrophages at 4, 24, 48, and 72 hpi.
Figure S5
Global changes in L. major and murine macrophage gene expression over the course of infection.
Figure S6
Mean-variance curve modeling and fitting of a local regression trend line by voom.
Table S1
KEGG pathways enriched among genes upregulated in L. major-infected murine macrophages at 24, 48, and 72 hpi.
Table S2
KEGG pathways enriched among genes downregulated in L. major-infected murine macrophages at 24, 48, and 72 hpi.
Figure S1
Per-gene counts (log2 counts per million) 
Value ( After log-transformation of the quantile-normalized data, the voom function in limma was used to compute the mean-variance relationship and to generate gene weights for use in the subsequent differential expression analysis. The relationships between mean expression (log2 counts per million with an offset of 0.5) and variance were modeled by voom for L. major (A) and mouse (B).
For each, a trend line was created using a local regression (loess). Trend line values (red line) are robust to genes with high variability and were used as gene weights by limma. ConsensusPathDB identified signaling and metabolic pathways that were over-represented among genes downregulated > 2-fold in L. major-infected mouse macrophages at 24, 48, and 72 hpi (P value < 0.01) relative to uninfected controls. For each enriched KEGG pathway, the number of differentially expressed (DE) genes belonging to that pathway, the total number of genes in the pathway, and the P value for the enrichment are reported. The DE genes corresponding to each enriched KEGG pathway are reported in Additional file 4.
